Saturday, 31 October 2026European Markets

ODFJELL SER. A And 2020 BULKERS Have A High Dividend Yield And Return On Equity In The Industrials Sector.

Loading stream...

(VIANEWS) - ODFJELL SER. A (ODF.OL) is among this list of stock assets with the highest dividend rate and return on equity on the Industrials sector.

Financial Asset Price Forward Dividend Yield Return on Equity
ODFJELL SER. A (ODF.OL) kr91.20 10.43% 27.96%
2020 BULKERS (2020.OL) kr98.10 8.05% 17.52%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. ODFJELL SER. A (ODF.OL)

10.43% Forward Dividend Yield and 27.96% Return On Equity

Odfjell SE engages in the transportation and storage of bulk liquid chemicals, acids, edible oils, and other special products. The company operates Chemical Tankers and Tank Terminals segments. It owns and operates chemical tankers that offers global and regional transportation; and tank terminals, which provides storage of various chemical and petroleum products. As of December 31, 2022, it operated a chemical tanker fleet of 69 vessels, including 46 owned, 6 bareboat chartered, 14 time chartered vessels, and 3 pool vessels. The company's terminal network comprises of 450 tanks with 1.2 million cubic meters of storage capacity. It operates in Norway, the Netherlands, rest of Europe, North America, South America, the Middle East, Asia, Australasia, and Africa. Odfjell SE was founded in 1914 and is headquartered in Bergen, Norway.

Earnings Per Share

As for profitability, ODFJELL SER. A has a trailing twelve months EPS of kr23.79.

PE Ratio

ODFJELL SER. A has a trailing twelve months price to earnings ratio of 3.83. Meaning, the purchaser of the share is investing kr3.83 for every norwegian krone of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 27.96%.

Growth Estimates Quarters

The company's growth estimates for the present quarter and the next is 74.7% and 12.7%, respectively.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Feb 13, 2023, the estimated forward annual dividend rate is 9.37 and the estimated forward annual dividend yield is 10.43%.

Yearly Top and Bottom Value

ODFJELL SER. A's stock is valued at kr91.20 at 17:30 EST, way below its 52-week high of kr107.00 and way higher than its 52-week low of kr50.60.

More news about ODFJELL SER. A.

2. 2020 BULKERS (2020.OL)

8.05% Forward Dividend Yield and 17.52% Return On Equity

2020 Bulkers Ltd. owns and operates large dry bulk vessels worldwide. It operates eight scrubber fitted 208,000 deadweight tonnage Newcastlemax dry bulk vessels. The company was incorporated in 2017 and is based in Hamilton, Bermuda.

Earnings Per Share

As for profitability, 2020 BULKERS has a trailing twelve months EPS of kr11.93.

PE Ratio

2020 BULKERS has a trailing twelve months price to earnings ratio of 8.22. Meaning, the purchaser of the share is investing kr8.22 for every norwegian krone of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.52%.

Sales Growth

2020 BULKERS's sales growth is negative 92.7% for the ongoing quarter and negative 86.1% for the next.

More news about 2020 BULKERS.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com